Medications | ||
Route | Dose and frequency | |
ESAs* | ||
Darbepoetin alfa (our preferred choice) | SUBQ/IV |
|
Epoetin alfa | SUBQ |
|
Epoetin alfa | SUBQ |
|
Epoetin alfa | IV |
|
IronΔ | ||
Enteral iron (used in neonates tolerating enteral feeds) | ||
| PO |
|
IV iron (an option for neonates not yet tolerating enteral feeds) | ||
| IV |
|
| IV |
|
Other supplements¥ | ||
Multivitamin | PO |
|
Monitoring | ||
| ||
Treatment discontinuation | ||
|
ANC: absolute neutrophil count; CGA: corrected gestational age; ELBW: extremely low birth weight (<1000 g); ESA: erythropoiesis stimulating agent; HCT: hematocrit; Hgb: hemoglobin; IV: intravenous; MVI: multi-vitamin infusion; PO: per os (by mouth); ret-He: reticulocyte hemoglobin content; SUBQ: subcutaneous; TPN: total parenteral nutrition; VLBW: very low birth weight (<1500 g).
* We recommend preservative-free medications. If darbepoetin is not available, epoetin alfa is an acceptable alternative.
¶ Parenteral epoetin alfa may be administered with TPN as a 24-hour infusion.
Δ When determining the total dose of iron supplementation, all sources of iron should be accounted for (eg, from human milk or formula, MVI, and direct supplementation with iron).
◊ Ferrous sulfate dosing is expressed in terms of elemental iron. Ferrous sulfate oral liquid preparations contain 20% elemental iron. Multiple product concentrations exist; use caution when ordering and switching between products.
§ A test dose of IV iron dextran is recommended prior to starting maintenance dosing.
¥ Some UpToDate experts administer folate (50 micrograms/day) and either an MVI or vitamin E (15 to 25 IU/day) when infants are no longer receiving TPN. Folate is not included in MVI supplements.
‡ For ELBW infants, ESAs can be discontinued if the Hct is >50% after 2 weeks of age. ESAs should be restarted if the Hct decreases to <30% and the infant is <34 to 36 weeks gestation.